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lowed prospectively for cardiovascular events after screening for baseline cardiovascular 
risks and cTnl. Patients who had suffered any acute coronary event within the preceding 
30 days were excluded from the study. 
Results: A total of one hundred and thirty seven patients were enrolled (mean age 58 
years, 52% males), Of these 7.3% (101137) had elevated cTnl levels when a cutoff of 
>1.0ng/ml was used, Controlling for other known cardiovascular dsk factors (age, diabetes, 
hypertension, family history of coronary artery disease, smoking, sex, CPK, homccys- 
teine), at 6 months 40% of patients with cTnl>1.0ng/ml had an event while 8% of those with 
normal cTnl levels had an event (OR = 9.7, CI = 1.9 - 50.6, p < 0.01)). At one year the 
event rate was 60% vs. 16.5% respectively (OR = 4.1, CI = 1.5 - 11.5, p < 0.01). 
Concluelon: Our study of stable chronic hemodialysis patients shows a high incidence of 
cardiovascular events in all subjects in long-term follow-up, especially in those with ele- 
vated baseline cTnl levels. However, the additional cardiac risk conferred by an elevated 
cTnl level in this population may warrant an even more aggressive approach to risk factor 
modification and this should be the basis for further studies. 
2:30 p.m. 
861-3 The Influence of Acute Coronary Syndromes on 
Comparative Changes in Functional Status  at 6 and 12 
Months Following CABG and PCh Results From the 
SOS Trial 
Zefeno Zhano, On Behalf of SOS Investigators, Emory Universi~ Atlanta, Georgia. 
Background: The SOS trial compared CABG vs. PCI with stent in patients (pts) with 
multi-vessel coronary artery disease. Previous results reported significant improvement 
in health status using the Seattle Angina Questionnaire (SAQ) for both treatment arms at 
6 and 12 months, with increased benefit for CABG pts. It is not known whether these 
results apply to pts with and without acute coronary syndromes (ACS). Methods: The 
SAQ assesses 5 domains: physical limitation (PL), angina stability (AS), angina fre- 
quency (AF), treatment satisfaction (TS) and disease perception (QOL), and was admin- 
istered at baseline, 6 and 12 months. Higher scores indicate better functioning. Analysis 
of covariance was used to compare improvements in SAQ scores.according to treatment 
and ACS adjusting for baseline SAQ scores and other factors. 
Results: 24.5% of SOS pts had ACS at randomization. There were more women and 
higher rates of prior MI, class Ill/IV angina and current smokers among pts with ACS. Pts 
with ACS had lower AF, AS and QOL scores at baseline. There was a significant interac- 
tion between treatment arm and ACS, whereby pts without ACS who underwent CABG 
had greater improvements in all but the TS domain than PCI counterparts, at both 6 and 
12 months. Among pts with ACS, improvements in SAQ scores tended to be similar for 
both treatment arms. 
Conclusions: For pts with multi-vessel disease, the greater improvement in health status 
for CABG vs. PCI is largely limited to pts who do not have ACS. 
The Estimated Mean Difference in SAQ Scores 
According to Treatment Arms and ACS 
ACS Non-ACS 
PCI CABG p value PCI CABG p value 
(n=116) (n=126) (n=372) (n=374) 
6-month 
PL 13.7 16.5 .330 12.5 17.3 .002 
AS 35.7 40.7 ,200 28.3 39.8 <.0001 
AF 30.6 36.4 .040 26.1 33.4 <.0001 
TS 1.2 1.8 .745 2.5 4.3 .108 
QOL 26.2 28.4 .474 25.9 31.9 .0004 
1-year 
PL 14.8 17.4 .350 13.2 17.3 .006 
AS 41.4 41.3 .968 31.6 36.2 .032 
AF 33.6 35.8 .376 28.5 33.2 .0006 
TS 3.7 3.6 .960 4.7 3.9 .493 
QOL 31.9 33.6 .578 31.8 35.2 .036 
2:45 p.m. 
861-4 Prediction of Risk in Patients With Unstable Angina and 
Non-ST Elevation Myocardial Infarction: A Prospective 
Comparison of the New ACC/AHA Guidelines and 
Physician Predicted Risk 
All F. Sonel, Jeffrey Whittle, Chester B. Good, Mary Kelley, VA Pittsburgh Healthcare 
System, Pittsburgh, Pennsylvania, University of Pittsburgh, Pittsburgh, Pennsylvania. 
Background: Recently published ACC/AHA guidelines for the management of patients 
with unstable angina and non-ST segment elevation myocardial infarction (MI) provide 
parameters for predicting short-term risk of death or MI. These parameters are used to 
determine eligibility for certain newer treatments. Their performance in actual practice 
settings is not well studied. 
Methods:We prospectively evaluated 215 consecutive patients admitted for symptoms 
suspicious for myocardial injury, The presence of each published guideline risk factor 
was determined by medical record review. Serial ECGs were interpreted in blinded fash- 
ion. The physicians caring for each patient were asked to give an assessment for 3O-day 
risk of death or MI. The study end point was 30-day death or new non-fatal MI following 
the index presentation. 
Results:Mean age was 68 ±11 (97% male). Overall 91% of patients had at least one 
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high-risk feature by the ACC/AHA guidelines compared to 48% when only the ECG and 
cardiac marker criteria were used. The physicians initially assessing the patients identi- 
fied only 13% of patients as being high-risk. During follow up 24 patients (11%) had 
events (18 deaths, 6 MI). In univariate analysis, only accelerating tempo of ischemic 
symptoms (p=0.03), pulmonary edema due to ischemia (p<0.0001) and physician esti- 
mate of high risk (p<O.0001) predicted events. In multivariabie analysis only pulmonary 
edema due to ischemia (p=0.015, OR-6.1) and physician predicted risk (p<0.0001, OR- 
9.8) were predictive of events. Physician judgement had higher positive predictive value 
(44%) than either the guidelines (10%) or a subset of the guidelines including only mark- 
ers and ECG findings (12%). While all three assessments provided high negative predic- 
tive value, physician prediction was slightly better (95%) than the guidelines (85%) or the 
marker/ECG subset (91%). 
Conclusion: Compared to physician assessment, current guidelines classified many 
more patients with suspected myocardial injury as being high risk. The low specificity of 
the guidelines suggests they should not be relied upon as a means to identify high risk 
patients. Clinician's risk assessment appears to be a more reliable predictor of events. 
3:00 p.m. 
861-5 The Ital ian Nat ional  Regist ry  of  Coronary Care Units: 
Initial Results From an Internet Based, Patient-Care 
Oriented Data Management Tool 
Marco Tubaro. Luigi Badano, Antonio Falcone, Enrico Neri, Christian Pnstipino, Massimo 
Zoni-Berisso, Domenico Cianflone, on behalf of G8Cardio-ANMCO, Project 
Coordination, Rome - Florence. 
Background: Conventional muiticenter surveys and registries impose additional workload 
to patient care and may not reflect the relevance, at a national level, of the collected data 
due to an uneven distribution/selection of participating centers. To overcome these limita- 
tions we developed and tested an internet based Registry of coronary care units (CCUs) 
relying on a =point-of-care" approach to the collection of individual patient data. 
Methods: In the framework of the National Cardiovascular Database, the GSCardio- 
ANMCO Project, we developed a tool for collecting clinical data for patients admitted to 
CCUs and for generating discharge summahes. The application was developed with SQL 
development ools and manages the collection of >250 core data elements, including key 
core elements for diagnostic and interventional procedures performed to CCU patients. 
The application and a secure internet access to the National Database Server, which con- 
solidates all the peripheral databases, were progressively provided to the 130 participating 
CCUs. In the timeframe november 2000 - july 2001, 43 CCUs participated in the testing 
phase. Data from 5573 patients were uploaded and analyzed to asses the feasibility of this 
approach. 
Results: Most frequent reason for admissions were as follows: 2268 AMI (66% ST-eleva- 
tion MI, 22%non-ST-Elevation, 2% Undetermined), 1241 Unstable Angina (57% in >_ 3B 
Braunwald class), 453 chest pain of unknown origin, 487 congestive heart failure (53% 
acute pulmonary (>edema), 413 severe arrhytmias (69% advanced AV block). The analysis 
of AMI data showed among other items: 36% AMI were preceded by UA; 17% of patients 
had no major risk factors and 61% did not undergo any reperfusion strategies. The analysis 
of UA data showed that 83% of patients were on aspirin (of the remaining 17% only 1.5% 
did not take any antiplatelet nor heparins) and a 18% incidence of elevated troponins. 
Conclusions: This "point-of-care" approach to data collection for registries and surveys is 
feasible and reliable. The shifting of the workload and costs of data collection for outcome 
research and health surveys to the actual patient care opens the way to larger and more 
accurate registries. 
3:15 p.m. 
861-6 Frequency of Use and Cost Implications of 
Complementary and Alternative Medicine Among Acute 
Coronary Syndrome Patients 
Prasanth Linoam. Sumit Sharma, Christopher R. McBumey, Sara Warper, Rajendra H. 
Mehta, Kim A. Eagle, Eva M. Kline-Rogers, University of Michigan Health Systems, Ann 
Arbor, Michigan. 
Background: Complementary and Alternative Medicine (CAM) use is increasing in 
patients admitted for acute coronary syndrome (ACS). The prevalence, type, and the 
reasons for CAM use in ACS patients are currently unknown. Little information exists on 
the cost implications of CAM use. 
Methods: We evaluated 145 patients discharged alive from the University of Michigan 
Health Systems after admission for ACS between August 2000 to January 2001. Clinical 
information was obtained retrospectively from medical records. Six months after dis- 
charge, after informed consent was obtained, all patients were interviewed by telephone 
using a standardized questionnaire to determine average CAM use. Food supplement 
prices were calculated using an average price from five area stores, while practitioner 
dependent CAM therapy pdces were obtained through a survey of five area centers. 
Results: Of the 145, 73.8% used CAM (mean age 64 years, discharge diagnosis of AMI 
55%, males 67%). Food supplements, vitamins and herbs were the most commonly used 
CAM therapy (60%). Mind-body techniques were second (29%), of which prayer was the 
leading therapy (25% of all users). Other CAM included body-based methods (22%), of 
which chiropractic use was 17%; energy-healing (4%) and chelation therapy (3%). 
Among CAM users, symptom relief was the most common reason for starting CAM 
(60%), Most users learned about CAM from family or friends (54%), while (36%) learned 
about it from a health care professional. When asked their biggest concerns about CAM, 
33% of users stated "lack of effectiveness," 21% stated "additional financial burden," 
while 41% had "no concerns." On average, a CAM user spent an additional $10 a month 
on food supplements. Body-based CAM users spent an average of $204 a month on 
therapies such as chelation, mind-body, body-based and energy healing techniques. 
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Concluelon: CAM therapy was prevalent among our ACS patients with most using CAM 
for symptom relief and leaming about it from their family and fdends, with an average out 
of pocket cost of $92 a month. Given the high prevalence of use and cost, it is essential 
that medical science investigate the efficacy and potential risks of CAM in patients with 
coronary artery disease. 
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1215-163 Underprescr lb lng  Ang io tens in  Conver t ing  Enzyme 
Inhibitors in Heart Failure: A Missed Economic 
Oppor tun i ty  
SteDhania K. Hauser. Marc F. Botteman, Joseph A. Gdcar, Zoe Kopp, Chris L. Pashos, 
Hadan M. Krumholz, Abt Associates Clinical Trials, Cambridge, Massachusetts, Yale 
University School of Medicine, New Haven, ConnecticuL 
Background: Despite demonstrated benefits and recommendations by national guide- 
lines, angiotensin converting-enzyme inhibitors (ACE-I) are underpresoribed in left-van- 
tricular systolic dysfunction (LVSD) and heart failure (HF). The impact of underutilization 
has not been quantified in the United States. Our objective was to estimate the annual 
clinical end economic impact of ACE-I underprescdbing in patients identified as ideal 
candidates for, but not receiving, ACE-I, and the cost effectiveness of prescribing ACE-I 
in these patients. 
Methods: The number of potential candidates not receiving ACE-I was determined from 
the literature, This population was categorized into 3 cohorts corresponding to the popu- 
lations from large prospective studies: symptomatic chronic systolic HF (SOLVD-Type), 
post-myocardial infarction (MI) HF (AIRE-Tybe), and post-MI, asymptomatic LVSD 
(SAVE-Typa). Based on the Uterature, we estimated the economic burden of underpre- 
scdbing ACE-I in terms of excess hospitalizations, direct medical costs (inpatient and 
ACE-I drug costs), deaths, and life-years lost. 
Results: We estimate that more than 280,000 ideal candidates for ACE-I fail to receive 
treatment, of which 187,850 are SOLVD-Type, 60,771 AIRE-Type, and 32,566 SAVE- 
Type. ACE-I use in these patients could potentially prevent 2,217, 2,486, and 436 prema- 
ture deaths, respectively, and save 4,878, 5,469 and 960 years of life annually, respec- 
tively. Similarly, 12,645, 3,403, and 235 hospital stays could be averted annually, 
avoiding $126.6 mil, $34 mil, and $2.4 rail in hospital costs, respectively. Upon inclusion 
of drug cost ($390 per patient per year), ACE-I treatment in these populations was pro- 
jected to result in net cost savings of $53 rail (SOLVD-Type) and $10 rail (AIRE-Type) 
and in a net cost of $10 mil (SAVE-Type) annually. Thus, treating patients in the first two 
groups was projected to save both lives and costs, whereas treating patients in the third 
group was projected to cost $10,800 per life-year saved. 
Conclusion: Treating the estimated 280,000 patients with LVSD or HF who could benefit 
from ACE-I therapy is an economically attractive investment o improve quality of care. 
1215-168 Physician Specialty and Quality of Care for Elderly 
Pat ients  Hosp i ta l i zed  With Heart  Fa i lure 
JoAnna M. Foodv. Salf S, Rathore, Yongfei Wang, Frederick A. Masoudi, Edward P. 
Havranek, Diana L. Ordin, Harlan M. Krumholz, Centers for Medicare and Medicaid 
Services, Yale University School of Medicine, New Haven, Connecticut, Colorodo 
Foundation for Medical Care, Denver, Colorado. 
Background.Whether specialist care is associated with better quality of care remains contro- 
versial.We sought to determine whether attending physician specialty is associated with 
indicators of quality of care among elderly patients hospitalized with heart failure (HF). Meth- 
ods: We studied a national sample of 26,305 Medicare patients age --65 years admitted to a 
hospital with HF in 1998-99 to determine whether the specialty of the attending physician 
was associated with quality of care. Patients were catsgodzed by physician specialty (cardi- 
ologist, internist or family practitioner) and evaluated for the use of 9 quality of care indica- 
tors among patients eligible for treatment with no contrsindicetions. Results: Cardiologists 
were most likely to assess EF dudng hospital stay. In patients in whom EF was shown to be 
low, the rates of presodption of ACE-I did not vary by specialty. Overall rates for counseling 
were low irrespective of specialty, although cardiologists were more likely to counsel regard- 
ing weight monitoring, worsening symptoms, and follow.up, but were less likely to document 
smoking cessation counseling (see Table). Conclusions: In this national sample of older 
patient hospitalized with HF, the specialty of the attending physician was associated with lit- 
tle absolute difference in these 9 process indicators. Irrespective of specialty, significant 
opportunities for improvement exist in the care of older patients with HF. 
Quality Indicator Cardiologist Internist Family Practitioner p 
Assessment of EF 52.3 50.6 45.7 <0.01 
ACE-I at Discharge 80.8 78. f 78.8 0.37 
Dicharge Counseling 
Smoking Cessation 18.5 25.6 24.1 0.11 
Medications 66.6 66.2 63.9 0.13 
Weight Monitoring 10.6 8.2 8.2 <0.01 
Diet 84.1 83.1 82~1 0.23 
Activity Level 77.0 75.3 76.9 0.22 
Follow-up Appointment 92.3 89.8 90.7 <0.01 
Worsening Symptoms 23.5 21.6 20.1 0.03 
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1215-169 Cardiologists Care for a Distinct CIInicel Subset of 
Older Patients Hospitalized With Heart Failure: 
Experience From the National Heart Failure Project 
JoAnna M. Foodv. Self S. Rathore, Yongfei Wang, Frederick A. Masoudi, Diana L. Ordin, 
Hadan M. Krumholz, Centers for Medicare and Medicaid Services, Yale University 
School of Medicine, New Haven, Connecticut, Colorado Foundation for Medical Care, 
Denver, Colorado. 
Background: Little is known about the proportion of older heart failure (HF) patients who 
have a cardiologist as their attending and whether these patients differ from those treated 
by other physicians. 
Methods: We studied 26,159 Medicare patients age >/= 65 years hospitalized with HF in 
1998-99 to determine the proportion of patients treated by cardiologists and to identify 
charactedstics associated with having a cardiologist as an attending. Demographic, clini- 
cal, geographic, and hospital charactedstics were evaluated in a backward stepwise 
polytomous logistic regression model to identify factors associated with cardiologist care 
compared with internist (IM) or family practitioner (FP) care. 
Results: Cardiologists cared for 25.5% of patients while IM and FP cared for 50.0% and 
24.5% of patients. Female patients (OR 0.91, 95%CI 0.83-1.00), older patients (OR 0.92, 
95% CI 0.90-0.95 par each year), and black patients (OR 0.84, 95% CI 0.71-0.99), were 
less likely to have cardiologist care. Patients with COPD (OR 0.70, 95% CI 0.63-0.75), 
dementia (OR 0.59, 95% CI 0.49-0.71), and diabetes (OR 0.79, 95% CI 0,72-0.87)were 
less likely to be treated by a cardiologist, while patients with prior HF (OR 1.15, 95% CI 
1.04-1.27) or coronary disease (OR 1.25, 95% CI 1.11-1,41) were more likely to receive 
cardiologist care. Patients treated in rural areas (OR 0.59, 95% CI 0.50-0.70), in the Mid- 
west (OR 0,71, 95% CI 0,60-0.84 vs Northeast), and in hospitals without cardiac care 
facilities or hospitals with only a cardiac catheterization lab (OR 0.75, 95% CI 0.64-0.88 
and OR 0.65, 95% CI 0.56-0.75 respectively vs with CABG facilities) were less likely to 
be treated by a cardiologist. Patients hospitalized at for-profit hospitals (OR 127, 95% 
C1-1.06-1.51 vs public) were more likely to have a cardiologist as their attending. 
Conclusions: Cardiologists were attandiogs for only one fourth of older patients hospital- 
ized with HF. These patients are younger with less comorbidity than patients cared for by 
either internists or family practitioners. Case mix should be considered when making 
quality of care and outcomes comparisons between specialties. 
1215-170 Impact of Age, Gender, and Race on Quality of Care of 
Elderly Patients With Congeatlve Heart Failure 
Jav K. Amin, Michael J. Lim, Chih-Wen Pal, Gerriann Finnegan, Kim A. Eagle, Rajandra 
H. Mehta, University of Michigan, Ann Arbor, Michigan, Michigan Peer Review 
Organization, Plymouth, Michigan. 
Background: Congestive heart failure (CHF) is more common in the eldedy, females, 
and non-whites in the United States. However, the influence of age, gender, and race on 
the quality of care of CHF patients (pts) has not been extensively studied. 
Method,=: We evaluated 5871 Medicare beneficiaries admitted to 31 acute care hospitals 
in Southeast Michigan with CHF (1/1/98-12/31/98). Patients were identified retrospec- 
tively using ICD-9 codes for CHF. They were divided into 3 age groups: Group A (65 ~ 74 
years), Group B (75 _< 84 years) and Group C (-> 65 years). Quality indicators (in ideal 
patients) were evaluated among different age groups, gender, and race. 
ResultS: The quality care indicators and the impact of age, gender, and race are shown. 
(Table). There were no differences in the length of stay for the different age groups, gen- 
der, or race. One-year mortality was higher in whites compared to non-whites(36.9% vs. 
32.9%, p=. 005) with a trend towards higher 1 -year mortality with increasing age. Gender 
did not influence 1 -year mortality. 
Conclusion: Quality of care is adversely affected by increasing age end female gender 
in hospitalized CHF pts. This data identifies a significant opportunity for improvement in 
the quality of care in these hi~lh-dsk sub~reups that needs to be addressed. 
Quality Group AGroup BGroup C P Male Female P White Non- P 
Indicators n=1751 n=2369 n=1244 Value n=2329 n=3542 Value n=4410 white Value 
n=1461 
Discharge ACE- 80.4 77.6 75.2 0.429 78.1 78.7 0.804 76.0 84.4 0.001 
inhibitor/ARB 
(%) 
LVEF 70.3 69.4 62.1 0.001 70.1 66.5 0.004 68 67.8 0.88 
documented (%) 
Discharge 33 20 10.5 0.10 30.6 22.3 0.157 30.2 22.8 0.21 
smoking 
cessation 
counseling (%) 
Discharge 98.1 97.2 94.9 0.122 96.5 97.8 0.142 96.8 97.B 0.295 
written 
instructions (%) 
Weights 67.3 67.9 55.3 0.003 68.6 63 0.020 66.3 64.8 0.566 
measured, 
>50% hospital 
days (%) 
Discharge 56.4 44.6 28.4 0.002 47.2 44.4 0.575 46.9 42.4 0.448 
wadarin in CHF 
pts with atdal 
fibdllation (%) 
